Q4 2021 Holdings
Filed 2022-02-14 | 78 holdings | $186.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $39.8M | 500,000 | 21.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $31.9M | 700,000 | 17.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $27.8M | 1,668,909 | 15.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $23.6M | 3,170,872 | 12.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $16.4M | 762,079 | 8.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $15.0M | 1,679,442 | 8.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $13.1M | 900,000 | 7.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.7M | 50,000 | 3.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $4.4M | 1,154,424 | 2.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.9M | 100,000 | 2.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.0M | 392,167 | 1.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $163.7K | 10,505,550 | 0.1% |
| Turning Point Therapeutics I | COM | 90041T108 | $144.3K | 3,025,000 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $116.5K | 5,440,453 | 0.1% |
| Prometheus Biosciences Inc | COM | 74349U108 | $73.1K | 1,848,024 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $66.0K | 4,639,995 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $61.3K | 3,002,199 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $61.2K | 2,431,852 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $54.5K | 3,565,901 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $53.1K | 4,899,185 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $47.8K | 2,012,115 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $40.9K | 1,109,224 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $37.2K | 2,302,626 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $33.0K | 1,681,115 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $31.6K | 1,403,331 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $30.0K | 2,326,660 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $29.6K | 625,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $28.4K | 1,182,362 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $28.0K | 2,489,894 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $22.5K | 2,486,386 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $21.6K | 1,830,691 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $20.3K | 2,169,871 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $19.0K | 868,550 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $18.1K | 1,182,545 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $18.0K | 322,240 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $15.1K | 785,303 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $14.8K | 752,406 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $14.7K | 500,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $14.6K | 400,000 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $14.2K | 608,123 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $13.1K | 750,000 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $11.9K | 1,983,165 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $11.6K | 839,932 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $11.1K | 2,273,221 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.0K | 75,000 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $10.9K | 2,216,763 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $9.9K | 689,731 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $9.8K | 600,000 | 0.0% |
| Icosavax Inc | COM | 45114M109 | $9.8K | 426,393 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $8.8K | 150,000 | 0.0% |